About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Veritas In Silico Inc.(130A) Summary

130A
TSE Growth
Veritas In Silico Inc.
691
JPY
-67
(-8.84%)
Apr 4, 3:30 pm JST
4.73
USD
Apr 4, 2:30 am EDT
Result
PTS
outside of trading hours
680
Apr 4, 10:17 pm JST
Summary Chart Historical News Financial Result
PER
26.6
PBR
2.03
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 4, 2025
Opening Apr 4, 9:00 am
750 JPY 5.12 USD
Previous Close Apr 3
758 JPY 5.14 USD
High Apr 4, 9:00 am
750 JPY 5.12 USD
Low Apr 4, 1:51 pm
665 JPY 4.57 USD
Volume
63,200
Trading Value
0.04B JPY 0.30M USD
VWAP
696.01 JPY 4.77 USD
Minimum Trading Value
69,100 JPY 473 USD
Market Cap
4.48B JPY 0.03B USD
Number of Trades
214
Liquidity & Number of Trades
As of Apr 4, 2025
Liquidity
Mid
1-Year Average
307
1-Year High Oct 9, 2024
11,468
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 28, 2025 0 303,000
Mar 21, 2025 0 309,200
Mar 14, 2025 0 313,600
Mar 7, 2025 0 308,800
Feb 28, 2025 0 298,700
Company Profile
Veritas In Silico operates a platform business for small molecule and nucleic acid drug discovery targeting mRNA.
Sector
Pharmaceuticals
Veritas In Silico Inc. is a Japan-based bio-pharmaceutical company. The company develops a platform for small molecule and nucleic acid drug discovery, specializing in targeting mRNA. It focuses on diseases that cannot be addressed by conventional protein-targeted drug discovery approaches. Using their proprietary in silico RNA structure analysis technology, Veritas In Silico has realized a drug discovery approach that targets partial structures on mRNA. This enables the creation of pharmaceuticals that address unmet medical needs. The company collaborates with multiple pharmaceutical companies, promoting joint research based on their drug discovery platform "ibVIS". By targeting mRNA, Veritas In Silico aims to open up new possibilities in the field of drug discovery and development.